Echocardiography in atrial fibrillation

Journal of Cardiovascular Medicine

Volumn 7, Issue 7, 2006, Pages 498-504

  Corrado, Giovanni ^a,c   Klein, Allan L ^b   Santarone, Mauro ^a  

^a VALDUCE HOSPITAL   (Italy)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Ospedale Generale Valduce   (Italy)

Author keywords

Atrial fibrillation; Echocardiography

Indexed keywords

ANTICOAGULANT THERAPY; CARDIOVERSION; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART FUNCTION; HUMAN; MEDICAL ASSESSMENT; MONITORING; PROGNOSIS; PULMONARY VEIN; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SAFETY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; CATHETER ABLATION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; HUMANS;

EID: 33746653866     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000234768.50583.b8     Document Type: Review

References (71)

1. Peters NS, Shilling RJ, Kanagaratham P, Markides V. Atrial fibrillation: strategies to control, combat and cure. Lancet 2002; 359:593-603.
2. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: The Framingham Heart Study. Circulation 1994; 89:724-730.
3. Pritchett ELC. Drug therapy. Management of atrial fibrillation. N Engl J Med 1992; 326:1264-1271.
4. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997; 29:106-112.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987; 147:1561-1564.
6. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17:622-625.
7. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. The Framingham heart study. Circulation 1998; 98:946-952.
8. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 247:1825-1833.
9. Van Gelder I, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834-1840.
10. The AFFIRM investigators. Relationship between sinus rhythm, treatment and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004; 109:1509-1513.
11. Morris JJ Jr, Entman M, North WC, Kong Y, McIntosh H. The changes in cardiac output with reversion of atrial fibrillation to sinus rhythm. Circulation 1965; 31:670-678.
12. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1570-1573.
13. Kieny JR, Sacrez A, Facello A, Arbogast R, Bareiss P, Roul G, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13:1290-1295.
14. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001; 22:1852-1923.
15. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964; i:209-212.
16. Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation. Arch Intern Med 1998; 158:1316-1320.
17. Hurrel DG, Oh JK, Mahaoney DW, Miller FA, Seward JB. Short deceleration time of mitral valve E velocity; prognostic implications with atrial fibrillation versus sinus rhythm. J Am Soc Echocardiogr 1998; 11:450-457.
18. Nagueh SF, Kapelen HA, Quinones MA. Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation 1996; 94:2138-2145.
19. Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M, et al. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Am Heart J 1999; 137:494-499.
20. Parkash R, Green MS, Kerr CR, Connolly SJ, Klein GJ, Sheldon R, et al. The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004; 148:649-654.
21. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990; 82:792-797.
22. Van Gelder IC, Crijns HJ, Van Gilst WH, Hamer HP, Lie KL. Decrease of right and left atrial sizes after direct current electrical cardioversion in chronic atrial fibrillation. Am J Cardiol 1991; 67:93-95.
23. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63:193-197.
24. Volgman AS, Soble JS, Neumann A, Mukhtar KN, Iftikhar F, Vallesteros A, et al. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging 1996; 10:261-265.
25. Antonielli E, Pizzuti G, Palinkas A, Tanger M, Grubber N, Michelassi C, et al. Clinical value of left atrial appendage flow for prediction of long term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2002; 39:1443-1449.
26. The Stroke Prevention in Atrial Fibrillation investigators. Predictors of thromboembolism in atrial fibrillation: echocardiographic features of patients at risk. Ann Intern Med 1992; 116:6-12.
27. Benjamin ED, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995; 92:835-841.
28. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23:1535-1540.
29. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995; 123:817-822.
30. Omran H, Jung W, Rabahieh R, Wirtz P, Becher H, Illien S, et al. Imaging of thrombi and assessment of left atrial appendage function: a prospective study comparing transthoracic and transoesophageal echocardiography. Heart 1999; 81:192-198.
31. Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995; 92:160-163.
32. Corrado G, Tadeo G, Beretta S, Tagliagambe LM, Manzillo GF, Spata M, et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. A transesophageal echocardiographic study. Chest 1999; 115:140-143.
33. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344:1411-1420.
34. Fatkin D, Kelly RY, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23:961-969.
35. Leung DYC, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994; 24:755-762.
36. SPAF III Investigators. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998; 128:639-647.
37. Dawn B, Varma J, Singh P, Longacker RA, Stoddard MF. Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters. J Am Soc Echocardiogr 2005; 18:199-205.
38. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, et al. Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993; 22:1359-1366.
39. Stoddard MF, Dawkins PR, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995; 129:1204-1215.
40. Grimm RA, Leung DY, Black IW, Stewart WJ, Thomas JD, Klein AL. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. Am Heart J 1995; 130:174-176.
41. Manning WJ, Silverman DI, Katz SE, Riley MF, Doherty RM, Munson JT, et al. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1995; 75:624-626.
42. Bjerkelund C, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969; 23:208-216.
43. Weinberg DM, Mancini GBJ. Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol 1989; 63:745-746.
44. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992; 19:851-855.
45. Singer DE, Albers GW, Dalen JA, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126:429S-456S.
46. Black IW, Hopkins AP, Lee LC, Walsh WF. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993; 126:375-381.
47. Black IW, Fatkin D, Sagar KB, Khandheria BK, Leung DY, Galloway JM, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994; 89:2509-2513.
48. Antonielli E, Pizzuti A, Gandolfo N, Bosco M, Sclavo M, Magnacca M, et al. Transesophageal echocardiography before cardioversion in patients with atrial fibrillation: usefulness and limits. G Ital Cardiol 1995; 25:543-552.
49. Orsinelli DA, Pearson AC. Usefulness of multiplane transesophageal echocardiography in differentiating left atrial appendage thrombus from pectinate muscles. Am Heart J 1996; 131:622-623.
50. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25:452-459.
51. Manning WJ, Silverman DI, Gordon SPF, Krumholz HM, Douglas PS. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993; 328:750-755.
52. Corrado G, Santarone M, Beretta S, Tadeo G, Tagliagambe LM, Foglia-Manzillo G, et al. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience. Europace 2000; 2:119-126.
53. Weigner MJ, Thomas LR, Patel U, Schwartz JG, Burger AJ, Douglas PS, et al. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med 2001; 110:694-702.
54. Seidl K, Rameken M, Drögemüller A, Vater M, Brandt A, Schwacke H, et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. J Am Coll Cardiol 2002; 39:1436-1442.
55. Gallagher MM, Hennessy BJ, Edvardsson N, Hart CM, Shannon MS, Obel OA, et al. Embolic complications of direct current cardioversion of atrial arrhythemias: association with low-intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol 2002; 40:926-933.
56. Shen X, Li H, Rovang K, Hee T, Holmberg MJ, Mooss AN, et al. Prevalence of intra-atrial thrombi in atrial fibrillation patients with subtherapeutic International Normalized Ratios while taking conventional anticoagulation. Am J Cardiol 2002; 90:660-662.
57. Corrado G, Beretta A, Sormani L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, et al. Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion. Eur J Echocardiogr 2004; 5:257-261.
58. Murray RD, Shah A, Jasper SE, Goodman A, Deitcher SR, Katz WE, et al. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study. Am Heart J 2000; 139:1-7.
59. De Luca I, Sorino M, Del Salvatore B, De Luca L. A new therapeutic strategy for electrical cardioversion of atrial fibrillation. Ital Heart J 2001; 11:831-840.
60. Stellbrink C, Nixdorff U, Hofmann T. Safety and efficacy of enoxaparin compared with unfractioned heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation. The Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 2004; 109:997-1003.
61. Weiss R, Marcovitz P, Knight BP, Bahu M, Souza JJ, Zivin A, et al. Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter. Am J Cardiol 1998; 82:1052-1055.
62. Corrado G, Sgalambro A, Mantero A, Gentile F, Gasparini M, Bufalino R, et al. Thromboembolic risk in atrial flutter: the FLASIEC (Flutter Atriale Societa Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J 2001; 22:1042-1051.
63. Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R, Wolpert C, et al. Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol 2001; 38:778-784.
64. Lanzerotti CJ, Olshansky B. Thromboembolism in chronic atrial flutter: is the risk underestimated? J Am Coll Cardiol 1997; 30:1506-1511.
65. Seidl K, Hauer B, Schwick NG, Zellner D, Zahn R, Senges J. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 1998; 82:580-583.
66. Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation. Circulation 2002; 105:1887-1889.
67. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargarva M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as a first-line treatment of symptomatic atrial fibrillation. JAMA 2005; 293:2634-2640.
68. Saad EB, Marrouche NF, Saad CP, Ha E, Bash D, White RD, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emerging of a new clinical syndrome. Ann Intern Med 2003; 138:634-638.
69. Jongbloed MRM, Schalij MJ, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Bax JJ. Clinical applications of intracardiac echocardiography in interventional procedures. Heart 2005; 91:981-990.
70. Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol 2004; 43:1861-1867.
71. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 107:2710-2716.